Sanara MedTech Files 8-K with Financial Updates

Ticker: SMTI · Form: 8-K · Filed: Jun 20, 2024 · CIK: 714256

Sanara Medtech Inc. 8-K Filing Summary
FieldDetail
CompanySanara Medtech Inc. (SMTI)
Form Type8-K
Filed DateJun 20, 2024
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: 8-K, financial-disclosure, regulation-fd

TL;DR

Sanara MedTech dropped an 8-K on 6/20 - check financials and disclosures.

AI Summary

Sanara MedTech Inc. filed an 8-K on June 20, 2024, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's status as a Texas-incorporated entity with its principal executive offices located in Fort Worth, TX.

Why It Matters

This filing provides important updates and disclosures for investors regarding Sanara MedTech's financial status and regulatory compliance.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K, which typically contains disclosures and financial information without immediate, significant operational changes.

Key Numbers

  • 001-39678 — Commission File Number (Identifies the company's filing with the SEC.)
  • 59-2219994 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

  • Sanara MedTech Inc. (company) — Registrant
  • Texas (location) — State of incorporation
  • Fort Worth, TX (location) — Business address
  • June 20, 2024 (date) — Date of earliest event reported

FAQ

What specific financial statements or exhibits are being filed with this 8-K?

The filing indicates 'Financial Statements and Exhibits' are included, but the specific details of these documents are not provided in the header information.

What is the primary purpose of this 8-K filing for Sanara MedTech Inc.?

The filing is for a 'Current Report' pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, including 'Regulation FD Disclosure' and 'Financial Statements and Exhibits'.

When was Sanara MedTech Inc. incorporated, and where are its principal offices located?

Sanara MedTech Inc. is incorporated in Texas, and its business address is located at 1200 Summit Ave, Suite 414, Fort Worth, TX 76102.

Has Sanara MedTech Inc. operated under any former names?

Yes, the company formerly operated as WOUND MANAGEMENT TECHNOLOGIES, INC. (name change 20080611), MB SOFTWARE CORP (name change 19960805), and INAV TRAVEL CORPORATION (name change 19920703).

What is the SIC code for Sanara MedTech Inc.?

The Standard Industrial Classification (SIC) code for Sanara MedTech Inc. is 3842, which corresponds to 'ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES'.

Filing Stats: 690 words · 3 min read · ~2 pages · Grade level 10.4 · Accepted 2024-06-20 09:00:25

Key Financial Figures

  • $0.001 — nge on which registered Common Stock, $0.001 par value SMTI The Nasdaq Capital M

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. Sanara MedTech Inc. (the "Company") is furnishing a copy of an investor presentation (the "Presentation") that the Company intends to use, in whole or in part, in one or more meetings with investors or analysts, including in a webcast on June 20, 2024, at 11:00 a.m. (Central Time). A copy of the Presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. The information contained in the Presentation is summary information that is intended to be considered in the context of the Company's Securities and Exchange Commission filings and other public announcements that the Company may make, by press release or otherwise, from time to time. The Company undertakes no duty or obligation to publicly update or revise the information contained in the Presentation, although it may do so from time to time as its management believes is warranted. The information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that section. Further, the information in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filing. Item 7.01 of this Current Report on Form 8-K will not be deemed an admission as to the materiality of any information in this Current Report on Form 8-K that is required to be disclosed solely by Regulation FD.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Investor Presentation (furnished pursuant to Item 7.01). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 20, 2024 Sanara MedTech Inc . By: /s/ Michael D. McNeil Name: Michael D. McNeil Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.